US CDC seeks more data to assess vaccine risk, extends halt on Johnson & Johnson usage

Anil Panchal FXStreet

Having stopped the usage of Johnson & Johnson’s (J&J) coronavirus (COVID-19) vaccine in all 50 US states the previous day, US Centers for Disease Control and Prevention (CDC) extends the pause on the usage of the vaccine amid a lack of more data to assess the risk.

The CDC panel concludes without a vote and plans to identify a date for the next meeting related to pausing the J&J covid-19 vaccine by Friday, which aims to reconvene in a week to 10 days.

It should, however, be noted that CDC director Dr. Rochelle Walensky said, per New York Post, “Blood clots reported in recipients of the Johnson & Johnson vaccine are “similar” to the adverse reaction linked to AstraZeneca’s shot in Europe.”

Elsewhere, Novavax to participate in University of Oxford com-cov2 study comparing mixed covid-19 vaccine combos. The study will explore heterologous regimen of covid-19 vaccines from different manufacturers.

Read: Johnson & Johnson: To proactively delay rollout of vaccine in Europe

FX reaction

Given the absence of fresh news, coupled with thin trading in Asia, global markets mostly ignore the news. However, the same signals challenge to the market sentiment and may weigh on S&P 500 Futures.

Author

Anil Panchal

FXStreet

Anil Panchal has nearly 15 years of experience in tracking financial markets. With a keen interest in macroeconomics, Anil aptly tracks global news/updates and stays well-informed about the global financial moves and their implications.

EUR/USD looks sidelined around 1.1850

EUR/USD remains on the back foot, extending its bearish tone and sliding towards the 1.1850 area to print fresh daily lows on Monday. The move lower comes as the US Dollar gathers modest traction, with thin liquidity and subdued volatility amplifying price swings amid the US market holiday.

GBP/USD flirts with daily lows near 1.3630

GBP/USD has quickly given back Friday’s solid gains, turning lower at the start of the week and drifting back towards the 1.3630 area. The focus now shifts squarely to Tuesday’s UK labour market report, which is likely to keep the quid firmly in the spotlight and could set the tone for Cable’s next move.

Gold battle around $5,000 continues

Gold is giving back part of Friday’s sharp rebound, deflating below the key $5,000 mark per troy ounce as the new week gets underway. Modest gains in the US Dollar are keeping the metal in check, while thin trading conditions, due to the Presidents Day holiday in the US, are adding to the choppy and hesitant tone across markets.

Bitcoin consolidates as on-chain data show mixed signals

Bitcoin price has consolidated between $65,700 and $72,000 over the past nine days, with no clear directional bias. US-listed spot ETFs recorded a $359.91 million weekly outflow, marking the fourth consecutive week of withdrawals.

The week ahead: Key inflation readings and why the AI trade could be overdone

It is likely to be a quiet start to the week, with US markets closed on Monday for Presidents Day. European markets are higher across the board and gold is clinging to the $5,000 level after the tamer than expected CPI report in the US reduced haven flows to precious metals.

XRP steadies in narrow range as fund inflows, futures interest rise

Ripple is trading in a narrow range between $1.45 (immediate support) and $1.50 (resistance) at the time of writing on Monday. The remittance token extended its recovery last week, peaking at $1.67 on Sunday from the weekly open at $1.43.